OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

NCT02736175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Surgical Ocular Pain
Post-Surgical Ocular Inflammation

Interventions

DRUG: Dexamethasone
OTHER: Placebo Vehicle

Sponsor

Ocular Therapeutix, Inc.